TABLE 2 .
Pathotypes and phenotypic drug resistance and multidrug resistance phenotypes
| Antimicrobial class or phenotype |
Specific drug | % overall prevalence of resistance phenotype in Indian population |
Estimated fraction in infection type: |
||
|---|---|---|---|---|---|
| Pyelonephritis (n = 30) |
Septicemia (n = 27) |
Skin and soft tissue infections (n = 21) |
|||
| Quinolone/fluoroquinolone | Ciprofloxacin | 86 | 0.37 | 0.34 | 0.28 |
| Sulfonamide/trimethoprim | Co-trimoxazole | 72 | 0.43 | 0.36 | 0.21 |
| Aminoglycosides | Gentamicin | 31 | 0.33 | 0.41 | 0.25 |
| Phenicols/phosphonic acid derivatives | Chloramphenicol | 23 | 0.39 | 0.50 | 0.11 |
| Fosfomycin | 5 | 0.00 | 0.25 | 0.75 | |
| Tetracyclines | Tetracycline | 77 | 0.43 | 0.35 | 0.22 |
| ESBL phenotype | Cefotaxime | 85 | 0.36 | 0.36 | 0.27 |
| MBL phenotype | Meropenem | 06 | 0.00 | 0.16 | 0.83 |
| Multidrug resistance | 67 | 0.40 | 0.32 | 0.26 | |